Ordering
Available Variants1 g
CHJ.15322-1g
Price
€180.80
Available – Dispatch in 14 days
5 g
CHJ.15322-5g
Price
€619.20
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
1 g | CHJ.15322-1g | €180.80 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 g | CHJ.15322-5g | €619.20 |
potency: 916-964 μg per mg
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C16H16N5NaO7S2 |
|---|---|
| CAS Number | 64485-93-4 |
| Molecular Weight | 477.45 |
| UNSPSC Code | 51284136 |
| NACRES | NA.85 |
| PubChem Substance ID | 24278336 |
| EC Number | 264-915-9 |
| Beilstein/REAXYS Number | 5711411 |
| MDL number | MFCD00079073 |
Safety Information Handling visibility
| pictograms |
GHS08
 GHS08
|
|---|---|
| signalword | Danger |
| hcodes | H317,H334 |
| pcodes | P261 - P272 - P280 - P284 - P302 + P352 - P333 + P313 |
| Hazard Classifications | Resp. Sens. 1 - Skin Sens. 1 |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 2 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | dust mask type N95 (US), Eyeshields, Faceshields, Gloves |
Technical Overview & Applications Use-case context
Cefotaxime sodium salt, with a CAS number of 64485-93-4, is a third-generation cephalosporin antibiotic that exhibits broad-spectrum antibacterial activity. It is highly effective against a wide range of Gram-positive and Gram-negative bacteria, including those that produce beta-lactamase enzymes. The sodium salt form of cefotaxime is commonly used in pharmaceutical applications due to its improved solubility and stability. Cefotaxime sodium salt is typically administered via intravenous or intramuscular injection, and its pharmacokinetic properties allow for rapid distribution and high tissue penetration. As a result, it is often used to treat severe infections, including septicemia, meningitis, and respiratory tract infections, particularly in hospital settings where antibiotic resistance is a concern. Its efficacy and safety profile make it a valuable option for the treatment of various bacterial infections.
